JP2022502408A5 - - Google Patents

Info

Publication number
JP2022502408A5
JP2022502408A5 JP2021516939A JP2021516939A JP2022502408A5 JP 2022502408 A5 JP2022502408 A5 JP 2022502408A5 JP 2021516939 A JP2021516939 A JP 2021516939A JP 2021516939 A JP2021516939 A JP 2021516939A JP 2022502408 A5 JP2022502408 A5 JP 2022502408A5
Authority
JP
Japan
Prior art keywords
fgfr3
chondrodysplasia
pharmaceutical composition
bone disease
composition according
Prior art date
Application number
JP2021516939A
Other languages
English (en)
Japanese (ja)
Other versions
JP7390370B2 (ja
JPWO2020065034A5 (https=
JP2022502408A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/076241 external-priority patent/WO2020065034A1/en
Publication of JP2022502408A publication Critical patent/JP2022502408A/ja
Publication of JP2022502408A5 publication Critical patent/JP2022502408A5/ja
Publication of JPWO2020065034A5 publication Critical patent/JPWO2020065034A5/ja
Application granted granted Critical
Publication of JP7390370B2 publication Critical patent/JP7390370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021516939A 2018-09-28 2019-09-27 妊娠中のfgfr3関連骨疾患の処置ためのインフィグラチニブ Active JP7390370B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306275.1 2018-09-28
EP18306275 2018-09-28
PCT/EP2019/076241 WO2020065034A1 (en) 2018-09-28 2019-09-27 Infigratinib for treatment of fgfr3-related skeletal diseases during pregnancy

Publications (4)

Publication Number Publication Date
JP2022502408A JP2022502408A (ja) 2022-01-11
JP2022502408A5 true JP2022502408A5 (https=) 2022-07-07
JPWO2020065034A5 JPWO2020065034A5 (https=) 2022-07-07
JP7390370B2 JP7390370B2 (ja) 2023-12-01

Family

ID=63798918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021516939A Active JP7390370B2 (ja) 2018-09-28 2019-09-27 妊娠中のfgfr3関連骨疾患の処置ためのインフィグラチニブ

Country Status (5)

Country Link
US (2) US20220040175A1 (https=)
EP (1) EP3856187B1 (https=)
JP (1) JP7390370B2 (https=)
ES (1) ES3025795T3 (https=)
WO (1) WO2020065034A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021250198A1 (en) * 2020-06-11 2021-12-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of fgfr3-related cognitive deficit
CA3202267A1 (en) * 2020-12-18 2022-06-23 Riccardo Panicucci Methods of treating achondroplasia
EP4452271A1 (en) * 2021-12-20 2024-10-30 Institut National de la Santé et de la Recherche Médicale (INSERM) Use of a fgfr3 tyrosine kinase inhibitor for the treatment of fgfr-related bone repair and bone formation impairments
JP2026507903A (ja) * 2023-03-06 2026-03-06 キューイーディー セラピューティクス,インコーポレイテッド 骨格形成異常の治療方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133328B2 (en) * 2011-12-12 2015-09-15 Sa Des Eaux Minerales D'evian Saeme Plastic compositions and containers made thereof
WO2013088191A1 (en) * 2011-12-12 2013-06-20 Institut National De La Sante Et De La Recherche Medicale (Inserm) Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3

Similar Documents

Publication Publication Date Title
JP2022502408A5 (https=)
JP2018193377A5 (https=)
JP2014094951A5 (https=)
JP2017149726A5 (https=)
Sharma et al. Antidiarrhoeal activity of leaf extract of Celosia argentea in experimentally induced diarrhoea in rats
JP2016108327A5 (https=)
JP2021535175A5 (https=)
JP2021529829A5 (https=)
JP2021518318A5 (https=)
JP2018503687A5 (https=)
JP2019112416A5 (https=)
WO2017220050A3 (zh) 阿奇霉素的药物组合物及其止咳的医药用途
JPWO2020065034A5 (https=)
JP2017516757A5 (https=)
HRP20201135T1 (hr) Farmaceutski pripravak
JP2021511379A5 (https=)
NL162835C (nl) Werkwijze voor het bereiden van geneesmiddelen met bactericide, anthelmintische, virus inhibiterende, locaal-anesthetische en/of hypotensieve werking en aldus verkregen gevormde geneesmiddelen, alsmede werkwijze ter bereiding van hiervoor geschikte semicyclische amidinen.
CN113302185A (zh) 苯并呋喃-6-甲酰胺衍生物、其制备方法和药学上的应用
JP6838474B2 (ja) 固形組成物
GB990502A (en) Substituted 1,5-diaryl pyrroles
TH176480A (https=)
CN104072392A (zh) N-环丙基胍基乙酸的制备方法
CN309787691S (zh) 喂鸟器的主体
JP2019022520A5 (https=)
RU2018101015A (ru) Способ профилактики хронической гипоксии и задержки развития плода